Jason A. Amello
Board Member
Candel Therapeutics, Inc. (CADL)Chief Accounting Officer
TScan Therapeutics, Inc. (TCRX)Board Member
TScan Therapeutics, Inc. (TCRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
TScan Therapeutics, Inc. (TCRX)
SEC 8-K
Current2024-01-29–present
-
Current
2024-01-29–present
-
Current
2024-01-01–present
-
Current
-
2024-01-29–2026-09-02
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Chief Accounting Officer, Board Member, CFO
2024-01-01–present
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | TScan Therapeutics, Inc. (TCRX) | Chief Financial Officer and Treasurer | $520,000 | $1,275,995 |
| 2024 | TScan Therapeutics, Inc. (TCRX) | Chief Financial Officer and Treasurer | $463,542 | $3,733,892 |
| 2023 | Candel Therapeutics, Inc. (CADL) | Former Chief Financial Officer | $466,045 | $692,025 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.